Abstract
The polyamine (PA) metabolism is involved in cell proliferation and differentiation. Increased cellular PA levels are observed in different types of cancers. Products of PA oxidation induce apoptosis in cancer cells. These observations open a perspective to exploit the enzymes of PA catabolism as a target for anticancer drug design. The substances capable to enhance PA oxidation may become potential anticancer agents. The goal of our study was to explore how the mode of ligand binding with a PA catabolic enzyme is associated with its stimulatory or inhibitory effect upon PA oxidation. Murine N1-acetylpolyamine oxidase (5LFO) crystalline structure was used for molecular docking with ligands of various chemical structures. In vitro experiments were carried out to evaluate the action of the tested compounds upon PA oxidative deamination in a cell-free test system from rat liver. Two amino acid residues (Aps211 and Tyr204) in the structure of 5LFO were found to be significant for binding with the tested compounds. 19 out of 51 screened compounds were activators and 17 were inhibitors of oxidative deamination of PA. Taken together, these results enabled to construct a recognition model with characteristic descriptors depicting activators and inhibitors. The general tendency indicated that a strong interaction with Asp211 or Tyr204 was rather typical for activators. The understanding of how the structure determines the binding mode of compounds with PA catabolic enzyme may help in explanation of their structure–activity relationship and thus promote structure-based drug design.
Similar content being viewed by others
Data availability
The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- AA:
-
Amino acid
- APAO:
-
N-acetylpolyamine oxidase
- BENSpm:
-
Bis(ethyl)norspermine
- CPENSpm:
-
N1-cyclopropylmethyl-N1-ethylnorspermine
- FAD:
-
Flavine adenine dinucleotide
- N1-acetyl-Spm:
-
N1-acetylspermine
- PA(s):
-
Polyamine(s)
- PAO:
-
Polyamine oxidase
- PDB:
-
Protein Data Bank
- SMO:
-
Spermine oxidase
- SSAT:
-
Spermine/spermidine-N-acetyltransferase
- Spm:
-
Spermine
- Spd:
-
Spermidine
- MDL 72527:
-
N1,N4-bis(2,3-butadienyl)-1,4-butanediamine dihydrochloride
References
Adachi MS, Juarez PR, Fitzpatrick PF (2010) Mechanistic studies of human spermine oxidase: kinetic mechanism and pH effects. Biochemistry 49(2):386–392. https://doi.org/10.1021/bi9017945
Adachi MS, Taylor AB, Hart PJ, Fitzpatrick PF (2012) Mechanistic and structural analyses of the roles of active site residues in the yeast polyamine oxidase Fms1: characterization of the N195A and D94N Enzymes. Biochemistry 51(43):8690–8697. https://doi.org/10.1021/bi3011434
Amendola R, Cervelli M, Fratini E, Sallustio DE, Tempera G, Ueshima T, Mariottini P, Agostinelli E (2013) Reactive oxygen species spermine metabolites generated from amine oxidases and radiation represent a therapeutic gain in cancer treatments. Int J Oncol 43(3):813–820. https://doi.org/10.3892/ijo.2013.2013
Anderson AC (2012) Structure-based functional design of drugs: from target to lead compound. Methods Mol Biol 823:359–366. https://doi.org/10.1007/978-1-60327-216-2_23
Anh LT, Polyanskii KB, Andresyuk AN, Soldatenkov AT, Mamyrbekova ZhA, Kuleshova LN, Khrustalev VN (2004) Synthesis and molecular structure of 2,4,8a-triaryl-6-methylperhydro[1,3,2]dioxaborinino [5,4-c] pyridines. Russ Chem Bull Int Ed 53(4):842–845
Anh LT, Hieu TH, Soldatenkov AT, Kolyadina NM, Khrustalev VN (2012a) 24-Acetyl-8,11,14-trioxa-24,27-diazapentacyclo-[19.5.1.122,26.02,7.015,20] octacosa-2,4,6,15(20),16,18-hexaen-28-one. Acta Crystallogr A E68:o2165–o2166
Anh LT, Hieu TH, Soldatenkov AT, Kolyadina NM, Khrustalev VN (2012b) Dimethyl 2-[22,24-dimethyl-23-oxo-8,11,14-trioxa-25-azatetracyclo [19.3.1.02,7.015,20] pentacosa-2,4,6,15(20),16,18-hexaen-25-yl]but-2-enedioate. Acta Crystallogr A E68:o1588–o1589
Anh LT, Hieu TH, Soldatenkov AT, Soldatova SA, Khrustalev VN (2012c) Dimethyl 2-(23-oxo-22,24-diphenyl-8,11,14-trioxa-25-azatetracyclo [19.3.1.02,7.015,20] pentacosa-2,4,6,15(20),16,18-hexaen-25-yl)but-2-enedioate. Acta Crystallogr A E68:o1386–o1387
Battu MB, Chandra AM, Sriram D, Yogeeswari P (2014) Pharmacophore-based 3DQSAR and molecular docking studies to identify new non-peptidic inhibitors of cathepsin S. Curr Med Chem 21(16):1910–1921. https://doi.org/10.2174/09298673113206660275
Bianchi M, Polticelli F, Ascenzi P, Botta M, Federico R, Mariottini P, Cona A (2006) Inhibition of polyamine and spermine oxidases by polyamine analogues. FEBS J 273(6):1115–1123. https://doi.org/10.1111/j.1742-4658.2006.05137.x
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Casero RA Jr, Frydman B, Stewart TM, Woster PM (2005) Significance of targeting polyamine metabolism as an antineoplastic strategy: unique targets for polyamine analogues. Proc West Pharmacol Soc 48:24–30 (review)
Cervelli M, Bellavia G, Fratini E et al (2010) Spermine oxidase (SMO) activity in breast tumor tissues and biochemical analysis of the anticancer spermine analogues BENSpm and CPENSpm. BMC Cancer 10:555. https://doi.org/10.1186/1471-2407-10-555
Cervelli M, Polticelli F, Fiorucci L, Angelucci E, Federico R, Mariottini P (2013) Inhibition of acetylpolyamine and spermineoxidases by the polyamine analogue chlorhexidine. J Enzym Inhib Med Chem 28(3):463–467. https://doi.org/10.3109/14756366.2011.650691
Cervelli M, Pietropaoli S, Signore F, Amendola R, Mariottini P (2014) Polyamines metabolism and breast cancer: state of the art and perspectives. Breast Cancer Res Treat 148(2):233–248. https://doi.org/10.1007/s10549-014-3156-7
Di Paolo ML, Cervelli M, Mariottini P et al (2019) Exploring the activity of polyamine analogues on polyamine and spermine oxidase: methoctramine, a potent and selective inhibitor of polyamine oxidase. J Enzym Inhib Med Chem 34(1):740–752. https://doi.org/10.1080/14756366.2019.1584620
Grancara S, Zonta F, Ohkubo S, Brunati AM, Agostinelli E, Toninello A (2015) Pathophysiological implications of mitochondrial oxidative stress mediated by mitochondriotropic agents and polyamines: the role of tyrosine phosphorylation. Amino Acids 47(5):869–883. https://doi.org/10.1007/s00726-015-1964-7
Handa AK, Fatima T, Mattoo AK (2018) Polyamines: bio-molecules with diverse functions in plant and human health and disease. Front Chem 6:10. https://doi.org/10.3389/fchem.2018.00010
Hieu TH, Anh LT, Soldatenkov AT, Kolyadina NM, Khrustalev VN (2012a) Dimethyl 2-[24-acetyl-28-oxo-8,11,14-trioxa-24,27-diazapentacyclo [19.5.1.122,26.02,7.015,20] octa-cosa-2,4,6,15(20),16,18-hexaen-27-yl] but-2-enedioate. Acta Crystallogr A E68:o2431–o2432
Hieu TH, Anh LT, Soldatenkov AT, Kurilkin VV, Khrustalev VN (2012b) Meso-(1S*,21R*)-25-Methyl-8,11,14-trioxa-22,24,25-triazatetracyclo[19.3.1.02,7.015,20] penta-cosa-2,4,6,15(20),16,18-hexaene-23-thione chloroform monosolvate. Acta Crystallogr A E68:o2848–o2849
Hieu TH, Anh LT, Soldatenkov AT, Vasil’ev VG, Khrustalev VN (2013) Ethyl 23-benzyl-8,11,14-trioxa-23,28,29-triazapentacyclo-[19.7.1.02,7.015,20.022,27] nonacosa-2,4,6,15(20),16,18,21,26-octaene-26-carboxylate. Acta Crystallogr A E69:o565–o566
Kaur P, Chamberlin AR, Poulos TL, Sevrioukova IF (2016) Structure-based inhibitor design for evaluation of a CYP3A4 pharmacophore model. J Med Chem 59(9):4210–4220. https://doi.org/10.1021/acs.jmedchem.5b01146
Khlebnikov AI, Schepetkin IA, Kirpotina LN, Brive L, Dahlgren C, Jutila MA, Quinn MT (2012) Molecular docking of 2-(benzimidazol-2-ylthio)-N-phenylacetamide-derived small-molecule agonists of human formyl peptide receptor 1. J Mol Model 18(6):2831–2843. https://doi.org/10.1007/s00894-011-1307-x
Libby PR, Munson BR, Fiel RJ, Porter CW (1995) Cationic porphyrin derivatives as inhibitors of polyamine catabolism. Biochem Pharmacol 50(9):1527–1530
Madeira F, Madhusoodanan N, Lee J, Tivey ARN, Lopez R (2019) Using EMBL-EBI services via web interface and programmatically via web services. Curr Protoc Bioinform. https://doi.org/10.1002/cpbi.74
Meanwell NA (2018) Fluorine and fluorinated motifs in the design and application of bioisosteres for drug design. J Med Chem. https://doi.org/10.1021/acs.jmedchem.7b01788
Miller-Fleming L, Olin-Sandoal V, Campbell K, Ralser M (2015) Remaining mysteries of molecular biology: the role of polyamine metabolites in the cell. J Mol Biol 427(21):3389–3406. https://doi.org/10.1016/j.jmb.2015.06.020
Moschou PN, Roubelakis-Angelakis KA (2014) Polyamines and programmed cell death. J Exp Bot 65(5):1285–1296. https://doi.org/10.1093/jxb/ert373
Murray-Stewart T, Ferrari E, Xie Y, Yu F, Marton LJ, Oupicky D, Casero RA (2017) Biochemical evaluation of the anticancer potential of the polyamine-based nanocarrier Nano11047. PLoS One 12(4):e0175917. https://doi.org/10.1371/journal.pone.0175917
Obakan P, Arisan ED, Calcabrini A, Agostinelli E, Bolkent S, Palavan-Unsal N (2014a) Activation of polyamine catabolic enzymes involved in diverse responses against epibrassinolide-induced apoptosis in LNCaP and DU145 prostate cancer cell lines. Amino Acids 46(3):553–564. https://doi.org/10.1007/s00726-013-1574-1
Obakan P, Arısan ED, Özfiliz P, Çoker-Gürkan A, Palavan-Ünsal N (2014b) Purvalanol A is a strong apoptotic inducer via activating polyamine catabolic pathway in MCF-7 estrogen receptor positive breast cancer cells. Mol Biol Rep 41(1):145–154. https://doi.org/10.1007/s11033-013-2847-1
Panidthananon W, Chaowasku T, Sritularak B, Likhitwitayawuid K (2018) A new benzophenone C-glucoside and other constituents of pseuduvaria fragrans and their α-glucosidase inhibitory activity. Molecules 23(7):1600. https://doi.org/10.3390/molecules23071600 (Published 2018 Jul 2)
Reinus B, Kerwin SM (2019) Preparation and utility of N-alkynyl azoles in synthesis. Molecules 24(3):422. https://doi.org/10.3390/molecules24030422
Samasil K, Lopes de Carvalho L, Mäenpää P, Salminen TA, Incharoensakdi A (2017) Biochemical characterization and homology modeling of polyamineoxidase from cyanobacterium Synechocystis sp. PCC 6803. Plant Physiol Biochem 119:159–169. https://doi.org/10.1016/j.plaphy.2017.08.018
Sjögren T, Wassvik CM, Snijder A, Aagaard A, Kumanomidou T, Barlind L, Kaminski TP, Kashima A, Yokota T, Fjellström O (2017) The structure of murine N1-acetylspermine oxidase reveals molecular details of vertebrate polyamine catabolism. Biochemistry 56(3):458–467. https://doi.org/10.1021/acs.biochem.6b01140
Sliwoski G, Kothiwale S, Meiler J, Lowe EW Jr (2013) Computational methods in drug discovery. Pharmacol Rev 66(1):334–395. https://doi.org/10.1124/pr.112.007336
Storer RJ, Ferrante A (1998) Hydrogen peroxide assay for amine oxidase activity. In: Morgan DML (ed) Methods in molecular biology: polyamine protocols, vol 79. Humana Press, Totowa, pp 59–68
Syatkin SP, Berezov TT (1982) Metabolism of polyamines in malignant tumors. Bull Acad Med Sci USSR 3:10–21 (in Russian)
Syatkin SP, Galaev YV (1977) Oxidation of putrescine, spermidine and spermine by mouse liver diaminoxidase. Biochemistry 42(6):1010–1013 (in Russian)
Syatkin SP, Kirichuk AA, Soldatenkov AT, Kutyakov SV, Neborak EV, Shevkun NA, Kuznetsova OM, Skorik AS, Terent’ev AA (2017) Screening of some dioxaborininopyridine and aniline derivatives for carcinogenic properties using a model cell-free system of regenerating rat liver. Bull Exp Biol Med 162:801. https://doi.org/10.1007/s10517-017-3717-y
Tavladoraki P, Cervelli M, Antonangeli F, Minervini G, Stano P, Federico R, Mariottini P, Polticelli F (2011) Probing mammalian spermine oxidase enzyme–substrate complex through molecular modeling, site-directed mutagenesis and biochemical characterization. Amino Acids 40:1115. https://doi.org/10.1007/s00726-010-0735-8
Thomas TJ, Thomas T (2018) Cellular and animal model studies on the growth inhibitory effects of polyamine analogues on breast cancer. Med Sci 6(1):24. https://doi.org/10.3390/medsci6010024
Volkov SV, Kutyakov SV, Levov AN, Polyakova EI, Le Tuan An, Soldatova SA, Terentyev PB, Soldatenkov AT (2007) Conversion of 3-benzoyl-1-methyl-4-phenyl-γ-piperidol under the action of arylamines and arylhydrazines. Synthesis of 3-arylamino-1-oxo-1-phenylpropanes and 1,3-diarylpyrazoles and their fragmentation under electron impact. Chem Heterocycl Compd 4:544–554
Vucicevic J, Nikolic K, Mitchell JBO (2017) Rational drug design of antineoplastic agents using 3D-QSAR, cheminformatic, and virtual screening approaches. Curr Med Chem. https://doi.org/10.2174/0929867324666170712115411
Wallace HM, Duthie J, Evans DM, Lamond S, Nicoll KM, Heys SD (2000) Alterations in polyamine catabolic enzymes in human breast cancer tissue. Clin Cancer Res 6(9):3657–3661
Wang Q, Wang Y, Wang K, Yang J, Cao C (2015) Polyamine analog TBP inhibits proliferation of human K562 chronic myelogenous leukemia cells by induced apoptosis. Oncol Lett 9:278–282. https://doi.org/10.3892/ol.2014.2615
Wang J, Li T, Zang L, Pan X, Wang S, Wu Y, Wang G (2017) Apigenin inhibits human SW620 cell growth by targeting polyamine catabolism. Evid Based Complement Altern Med 2017:3684581. https://doi.org/10.1155/2017/3684581
Acknowledgements
This work was financially supported by the Ministry of Education and Science of the Russian Federation (the Agreement No 02.A03.21.0008) and by the “RUDN University Program 5-100”. Docking studies were supported by Tomsk Polytechnic University Competitiveness Enhancement Program Grant No. CEP—N. Kizhner Center—213/2018. The authors thank the “International Polyamine Foundation, ONLUS” for the availability to look up in the Polyamines documentation.
Author information
Authors and Affiliations
Contributions
All authors listed have contributed to the conception, design, gathering, analysis, or interpretation of data, and have contributed to the writing and intellectual content of the article. All authors gave informed consent to the submission of this manuscript.
Corresponding author
Ethics declarations
Conflict of interest
All the authors confirm the permission for this publication and declare no conflict of interests.
Ethics approval and research involving human participants and/or animals
All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. The experiments with the animals were carried out according to the protocols approved by the Ethic Committee of PFUR (protocol no. 17/09-2015). This study does not contain any studies with human participants performed by any of the authors.
Additional information
Handling Editor: E. Closs.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Syatkin, S.P., Neborak, E.V., Khlebnikov, A.I. et al. The investigation of structure–activity relationship of polyamine-targeted synthetic compounds from different chemical groups. Amino Acids 52, 199–211 (2020). https://doi.org/10.1007/s00726-019-02778-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-019-02778-3